Pulmonx Corp
NASDAQ:LUNG
Pulmonx Corp
NASDAQ:LUNG
Price:
9.82 USD
4.69%
Market Closed
Updated:
May 6, 2024
Pulmonx Corp
Revenue
|
Pulmonx Corp
Revenue Peer Comparison
Comparables:
COO
XRAY
ALGN
LNTH
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Pulmonx Corp
NASDAQ:LUNG
|
Revenue
$68.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Revenue
$1.3B
|
CAGR 3-Years
56%
|
CAGR 5-Years
30%
|
CAGR 10-Years
16%
|
Pulmonx Corp
Revenue Breakdown
Breakdown by Geography
Pulmonx Corp
Pulmonx Corp
|
Total Revenue:
68.7m
USD
|
|
United States:
45.9m
USD
|
|
Europe, Middle-East and Africa (“EMEA”):
19.3m
USD
|
|
Asia Pacific:
3m
USD
|
|
Other International:
399k
USD
|
Breakdown by Segments
Pulmonx Corp
Pulmonx Corp
Not Available
See Also
What is Pulmonx Corp's Revenue?
Revenue
68.7m
USD
68.7m
USD
Based on the financial report for Dec 31, 2023, Pulmonx Corp's Revenue amounts to 68.7m USD.
What is Pulmonx Corp's Revenue growth rate?
Revenue CAGR 5Y
28%
28%
Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Pulmonx Corp have been 28% over the past three years , 28% over the past five years .
You don't have any saved screeners yet
